Display 46–60 of 69 results
Clear All

Sort by

Filter by Type

Filter by Subject

Apply

Comments

Nanotechnology Public Comments March 19, 2013

The Nanotechnology Panel comments on the National Institute for Occupational Safety and Healths (NIOSH) draft strategic plan for nanotechnology research, dockets CDC-2013-0001

Comments

Nanotechnology Public Comments July 24, 2012

The Nanotechnology Panel comments on the Food and Drug Administrations (FDA) draft guidance to industry titled Assessing the Effects of Significant Manufacturing Process Changes, Including Emerging Technologies, on the Safety and Regulatory Status of Food Ingredients and Food Contact Substances, Including Food Ingredients that Are Color Additives (FDA-2011-D-0490).

Comments

Nanotechnology Public Comments July 24, 2012 Cosmetics

The Nanotechnology Panel comments on the Food and Drug Administrations (FDA) draft guidance to industry titled Guidance for Industry: Safety of Nanomaterials in Cosmetic Products (FDA-2011-D-0489).

Comments

Cal Dooley Remarks at GlobalChem 2012

ACC President and CEO Cal Dooley points to an American manufacturing renaissance and discusses the impact of regulations on the global business of chemistry.

Comments

Nanotechnology Public Comments January 27, 2012

The Nanotechnology Panel comments on EPAs proposed significant new use rules (SNURs) under section 5(a)(2) of the Toic Substances Control Act (TSCA) for the chemical substances rutile, tin zinc, calcium-doped (CAS No. 389623012) and rutile, tin zinc, sodium-doped (CAS No. 389623078) published in the December 28, 2011 edition of the Federal Register, docket EPAHQOPPT20101075.

Comments

Nanotechnology Public Comments August 17, 2011

The Nanotechnology Panel (jointly submitted with the ACC Biocides Panel) comments on EPAs proposed policy statement concerning the collection of information about the presence of nanomaterials in pesticide products, docket EPAHQOPP20100197.

Comments

Nanotechnology Public Comments August 15, 2011

Nanotechnology Panel comments on the draft guidance Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology, docket FDA2010D0530.

Comments

Business Alliance Comments on Introduction of Chemical Safety Legislation in Senate

The American Alliance for Innovation, an alliance representing a broad spectrum of the economy, responded today to the introduction of the Safe Chemicals Act of 2011 by Senator Frank Lautenberg (D-N.J.) and called on Congress to modernize the Toic Substances Control Act (TSCA) in a manner that protects human health and the environment while fostering innovation and safeguarding American jobs.